Diversify Advisory Services LLC acquired a new stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,525 shares of the company’s stock, valued at approximately $703,000.
Several other large investors have also made changes to their positions in the business. Wealthfront Advisers LLC acquired a new stake in Molina Healthcare in the 2nd quarter valued at $782,000. Meeder Advisory Services Inc. acquired a new position in Molina Healthcare during the second quarter worth $355,000. Citizens Financial Group Inc. RI acquired a new position in Molina Healthcare during the second quarter worth $1,118,000. Texas Capital Bank Wealth Management Services Inc purchased a new position in Molina Healthcare during the second quarter valued at $250,000. Finally, BlackRock Inc. purchased a new position in Molina Healthcare during the second quarter valued at $1,503,052,000. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Trading Down 1.7%
MOH opened at $197.69 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68. The company’s 50 day simple moving average is $211.25 and its two-hundred day simple moving average is $178.42. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The firm has a market capitalization of $10.32 billion, a price-to-earnings ratio of -1,098.22, a price-to-earnings-growth ratio of 28.82 and a beta of 0.75.
Analysts Set New Price Targets
A number of analysts have recently commented on MOH shares. Morgan Stanley boosted their target price on shares of Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 4th. Truist Financial decreased their price target on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a research note on Friday, July 24th. Robert W. Baird lifted their price objective on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Mizuho set a $215.00 price objective on Molina Healthcare in a research note on Monday, June 8th. Finally, Wall Street Zen raised Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $202.44.
Get Our Latest Stock Report on Molina Healthcare
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
See Also
- Five stocks we like better than Molina Healthcare
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
